Eosinophils in Autoimmune Diseases
Tóm tắt
Từ khóa
Tài liệu tham khảo
Ohashi, 1991, Ablation of “tolerance” and induction of diabetes by virus infection in viral antigen transgenic mice, Cell, 65, 305, 10.1016/0092-8674(91)90164-T
Waldner, 2004, Activation of antigen-presenting cells by microbial products breaks self tolerance and induces autoimmune disease, J Clin Invest, 113, 990, 10.1172/JCI19388
Ichikawa, 2002, Activation of APCs through CD40 or toll-like receptor 9 overcomes tolerance and precipitates autoimmune disease, J Immunol, 169, 2781, 10.4049/jimmunol.169.5.2781
Fraker, 2016, The expanding role of natural killer cells in type 1 diabetes and immunotherapy, Curr Diab Rep, 16, 109, 10.1007/s11892-016-0806-7
Jiao, 2016, NK cell subtypes as regulators of autoimmune liver disease, Gastroenterol Res Pract, 2016, 6903496, 10.1155/2016/6903496
Zhou, 2016, Toll-like receptor-mediated immune responses in intestinal macrophages; implications for mucosal immunity and autoimmune diseases, Clin Immunol, 173, 81, 10.1016/j.clim.2016.09.005
Waldner, 2009, The role of innate immune responses in autoimmune disease development, Autoimmun Rev, 8, 400, 10.1016/j.autrev.2008.12.019
Sie, 2017, Dendritic cells in central nervous system autoimmunity, Semin Immunopathol, 39, 99, 10.1007/s00281-016-0608-7
Exley, 2016, What rheumatologists need to know about innate lymphocytes, Nat Rev Rheumatol, 12, 658, 10.1038/nrrheum.2016.140
Conti, 2016, Important role of mast cells in multiple sclerosis, Mult Scler Relat Disord, 5, 77, 10.1016/j.msard.2015.11.005
Lopez, 1986, Murine eosinophil differentiation factor. An eosinophil-specific colony-stimulating factor with activity for human cells, J Exp Med, 163, 1085, 10.1084/jem.163.5.1085
Rothenberg, 1988, Characterization of a human eosinophil proteoglycan, and augmentation of its biosynthesis and size by interleukin 3, interleukin 5, and granulocyte/macrophage colony stimulating factor, J Biol Chem, 263, 13901, 10.1016/S0021-9258(18)68329-2
Sanderson, 1992, Interleukin-5, eosinophils, and disease, Blood, 79, 3101, 10.1182/blood.V79.12.3101.bloodjournal79123101
Johnston, 2016, IL-33 precedes IL-5 in regulating eosinophil commitment and is required for eosinophil homeostasis, J Immunol, 197, 3445, 10.4049/jimmunol.1600611
Collins, 1995, Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo, J Exp Med, 182, 1169, 10.1084/jem.182.4.1169
Rothenberg, 2006, The eosinophil, Annu Rev Immunol, 24, 147, 10.1146/annurev.immunol.24.021605.090720
Matthews, 1998, Eotaxin is required for the baseline level of tissue eosinophils, Proc Natl Acad Sci U S A, 95, 6273, 10.1073/pnas.95.11.6273
Zhang, 2000, Expression of the chemokine eotaxin and its receptor, CCR3, in human endometrium, Biol Reprod, 62, 404, 10.1095/biolreprod62.2.404
Gouon-Evans, 2001, Eotaxin is required for eosinophil homing into the stroma of the pubertal and cycling uterus, Endocrinology, 142, 4515, 10.1210/endo.142.10.8459
Pope, 2005, The eotaxin chemokines and CCR3 are fundamental regulators of allergen-induced pulmonary eosinophilia, J Immunol, 175, 5341, 10.4049/jimmunol.175.8.5341
Ahrens, 2008, Intestinal macrophage/epithelial cell-derived CCL11/eotaxin-1 mediates eosinophil recruitment and function in pediatric ulcerative colitis, J Immunol, 181, 7390, 10.4049/jimmunol.181.10.7390
Diny, 2016, Macrophages and cardiac fibroblasts are the main producers of eotaxins and regulate eosinophil trafficking to the heart, Eur J Immunol, 46, 2749, 10.1002/eji.201646557
Kitaura, 1996, Molecular cloning of human eotaxin, an eosinophil-selective CC chemokine, and identification of a specific eosinophil eotaxin receptor, CC chemokine receptor 3, J Biol Chem, 271, 7725, 10.1074/jbc.271.13.7725
Kitaura, 1999, Molecular cloning of a novel human CC chemokine (Eotaxin-3) that is a functional ligand of CC chemokine receptor 3, J Biol Chem, 274, 27975, 10.1074/jbc.274.39.27975
Patel, 1997, Molecular and functional characterization of two novel human C-C chemokines as inhibitors of two distinct classes of myeloid progenitors, J Exp Med, 185, 1163, 10.1084/jem.185.7.1163
Lee, 2012, Human versus mouse eosinophils: “that which we call an eosinophil, by any other name would stain as red”, J Allergy Clin Immunol, 130, 572, 10.1016/j.jaci.2012.07.025
Sallusto, 1997, Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells, Science, 277, 2005, 10.1126/science.277.5334.2005
Bochner, 2015, Novel therapies for eosinophilic disorders, Immunol Allergy Clin North Am, 35, 577, 10.1016/j.iac.2015.05.007
Rosenberg, 2013, Eosinophils: changing perspectives in health and disease, Nat Rev Immunol, 13, 9, 10.1038/nri3341
Acharya, 2014, Eosinophil granule proteins: form and function, J Biol Chem, 289, 17406, 10.1074/jbc.R113.546218
Butterworth, 1979, Damage to schistosomula of Schistosoma mansoni induced directly by eosinophil major basic protein, J Immunol, 122, 221, 10.4049/jimmunol.122.1.221
Gleich, 1979, Cytotoxic properties of the eosinophil major basic protein, J Immunol, 123, 2925, 10.4049/jimmunol.123.6.2925
Frigas, 1980, Cytotoxic effects of the guinea pig eosinophil major basic protein on tracheal epithelium, Lab Invest, 42, 35
Zheutlin, 1984, Stimulation of basophil and rat mast cell histamine release by eosinophil granule-derived cationic proteins, J Immunol, 133, 2180, 10.4049/jimmunol.133.4.2180
Piliponsky, 2001, Human eosinophils induce histamine release from antigen-activated rat peritoneal mast cells: a possible role for mast cells in late-phase allergic reactions, J Allergy ClinImmunol, 107, 993, 10.1067/mai.2001.114656
Jacoby, 2001, Eosinophil recruitment to the airway nerves, J Allergy ClinImmunol, 107, 211, 10.1067/mai.2001.112940
Morgan, 2005, Diverse effects of eosinophil cationic granule proteins on IMR-32 nerve cell signaling and survival, Am J Respir Cell Mol Biol, 33, 169, 10.1165/rcmb.2005-0056OC
Rosenberg, 1989, Human eosinophil cationic protein. Molecular cloning of a cytotoxin and helminthotoxin with ribonuclease activity, J Exp Med, 170, 163, 10.1084/jem.170.1.163
Sorrentino, 1992, Eosinophil-derived neurotoxin and human liver ribonuclease. Identity of structure and linkage of neurotoxicity to nuclease activity, J Biol Chem, 267, 14859, 10.1016/S0021-9258(18)42119-9
Domachowske, 1998, Recombinant human eosinophil-derived neurotoxin/RNase 2 functions as an effective antiviral agent against respiratory syncytial virus, J Infect Dis, 177, 1458, 10.1086/515322
Yang, 2004, Human ribonuclease A superfamily members, eosinophil-derived neurotoxin and pancreatic ribonuclease, induce dendritic cell maturation and activation, J Immunol, 173, 6134, 10.4049/jimmunol.173.10.6134
Lacy, 2003, Divergence of mechanisms regulating respiratory burst in blood and sputum eosinophils and neutrophils from atopic subjects, J Immunol, 170, 2670, 10.4049/jimmunol.170.5.2670
Wang, 2006, Thiocyanate-dependent induction of endothelial cell adhesion molecule expression by phagocyte peroxidases: a novel HOSCN-specific oxidant mechanism to amplify inflammation, J Immunol, 177, 8714, 10.4049/jimmunol.177.12.8714
Wang, 2006, The principal eosinophil peroxidase product, HOSCN, is a uniquely potent phagocyte oxidant inducer of endothelial cell tissue factor activity: a potential mechanism for thrombosis in eosinophilic inflammatory states, Blood, 107, 558, 10.1182/blood-2005-05-2152
Dvorak, 1994, Vesicular transport of peroxidase in human eosinophilic myelocytes, Clin Exp Allergy, 24, 10, 10.1111/j.1365-2222.1994.tb00910.x
Melo, 2005, Human eosinophils secrete preformed, granule-stored interleukin-4 through distinct vesicular compartments, Traffic, 6, 1047, 10.1111/j.1600-0854.2005.00344.x
Spencer, 2006, Cytokine receptor-mediated trafficking of preformed IL-4 in eosinophils identifies an innate immune mechanism of cytokine secretion, Proc Natl Acad Sci U S A, 103, 3333, 10.1073/pnas.0508946103
Fischer, 1986, Human eosinophils express CR1 and CR3 complement receptors for cleavage fragments of C3, Cell Immunol, 97, 297, 10.1016/0008-8749(86)90400-4
Gounni, 1994, High-affinity IgE receptor on eosinophils is involved in defence against parasites, Nature, 367, 183, 10.1038/367183a0
Grangette, 1989, IgE receptor on human eosinophils (FcERII). Comparison with B cell CD23 and association with an adhesion molecule, J Immunol, 143, 3580, 10.4049/jimmunol.143.11.3580
Hartnell, 1992, IFN-gamma induces expression of Fc gamma RIII (CD16) on human eosinophils, J Immunol, 148, 1471, 10.4049/jimmunol.148.5.1471
Decot, 2005, Heterogeneity of expression of IgA receptors by human, mouse, and rat eosinophils, J Immunol, 174, 628, 10.4049/jimmunol.174.2.628
Hallam, 1982, Rat eosinophil-mediated antibody-dependent cellular cytotoxicity: investigations of the mechanisms of target cell lysis and inhibition by glucocorticoids, Clin Exp Immunol, 48, 641
Van Epps, 1978, Human eosinophils: surface receptors and antibody-dependent cytotoxicity, J Lab Clin Med, 91, 612
Parrillo, 1978, Human eosinophils. Purification and cytotoxic capability of eosinophils from patients with the hypereosinophilic syndrome, Blood, 51, 457, 10.1182/blood.V51.3.457.457
Noguchi, 1992, Tissue eosinophilia and eosinophil degranulation in syndromes associated with fibrosis, Am J Pathol, 140, 521
Phipps, 2002, The relationship between allergen-induced tissue eosinophilia and markers of repair and remodeling in human atopic skin, J Immunol, 169, 4604, 10.4049/jimmunol.169.8.4604
Birring, 2005, Sputum eosinophilia in idiopathic pulmonary fibrosis, Inflamm Res, 54, 51, 10.1007/s00011-004-1321-x
Corradi, 2004, Eosinophilic myocarditis in a patient with idiopathic hypereosinophilic syndrome: insights into mechanisms of myocardial cell death, Hum Pathol, 35, 1160, 10.1016/j.humpath.2004.05.008
Pincus, 1987, Eosinophils stimulate fibroblast DNA synthesis, Blood, 70, 572, 10.1182/blood.V70.2.572.572
Kay, 2004, A role for eosinophils in airway remodelling in asthma, Trends Immunol, 25, 477, 10.1016/j.it.2004.07.006
Minshall, 1997, Eosinophil-associated TGF-β1 mRNA expression and airways fibrosis in bronchial asthma, Am J Respir Cell Mol Biol, 17, 326, 10.1165/ajrcmb.17.3.2733
Hernnäs, 1992, Eosinophil cationic protein alters proteoglycan metabolism in human lung fibroblast cultures, Eur J Cell Biol, 59, 352
Pégorier, 2006, Eosinophil-derived cationic proteins activate the synthesis of remodeling factors by airway epithelial cells, J Immunol, 177, 4861, 10.4049/jimmunol.177.7.4861
Milici, 1998, Early eosinophil infiltration into the optic nerve of mice with experimental allergic encephalomyelitis, Lab Invest, 78, 1239
Costello, 1997, Localization of eosinophils to airway nerves and effect on neuronal M2 muscarinic receptor function, Am J Physiol, 273, L93
Fryer, 2006, Neuronal eotaxin and the effects of CCR3 antagonist on airway hyperreactivity and M2 receptor dysfunction, J Clin Invest, 116, 228, 10.1172/JCI25423
Smyth, 2013, Activated eosinophils in association with enteric nerves in inflammatory bowel disease, PLoS One, 8, e64216, 10.1371/journal.pone.0064216
Sawatzky, 2002, Eosinophil adhesion to cholinergic nerves via ICAM-1 and VCAM-1 and associated eosinophil degranulation, Am J Physiol Lung Cell Mol Physiol, 282, L1279, 10.1152/ajplung.00279.2001
Kingham, 2002, Adhesion-dependent interactions between eosinophils and cholinergic nerves, Am J Physiol Lung Cell Mol Physiol, 282, L1229, 10.1152/ajplung.00278.2001
Iwamoto, 1993, Mechanism for substance P-induced activation of human neutrophils and eosinophils, Regul Pept, 46, 228, 10.1016/0167-0115(93)90042-7
Sunohara, 1989, Neurotoxicity of human eosinophils towards peripheral nerves, J Neurol Sci, 92, 1, 10.1016/0022-510X(89)90170-6
Hogan, 2001, A pathological function for eotaxin and eosinophils in eosinophilic gastrointestinal inflammation, Nat Immunol, 2, 353, 10.1038/86365
Kobayashi, 2002, Human eosinophils produce neurotrophins and secrete nerve growth factor on immunologic stimuli, Blood, 99, 2214, 10.1182/blood.V99.6.2214
Kingham, 2003, Effects of eosinophils on nerve cell morphology and development: the role of reactive oxygen species and p38 MAP kinase, Am J Physiol Lung Cell Mol Physiol, 285, L915, 10.1152/ajplung.00094.2003
Garland, 1997, Activated eosinophils elicit substance P release from cultured dorsal root ganglion neurons, Am J Physiol, 273, L1096
Elbon, 1995, Pretreatment with an antibody to interleukin-5 prevents loss of pulmonary M2 muscarinic receptor function in antigen-challenged guinea pigs, Am J Respir Cell Mol Biol, 12, 320, 10.1165/ajrcmb.12.3.7873198
Yousefi, 2008, Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense, Nat Med, 14, 949, 10.1038/nm.1855
Simon, 2013, Extracellular DNA traps in allergic, infectious, and autoimmune diseases, Allergy, 68, 409, 10.1111/all.12111
Dworski, 2011, Eosinophil and neutrophil extracellular DNA traps in human allergic asthmatic airways, J Allergy Clin Immunol, 127, 1260, 10.1016/j.jaci.2010.12.1103
Simon, 2011, Eosinophil extracellular DNA traps in skin diseases, J Allergy Clin Immunol, 127, 194, 10.1016/j.jaci.2010.11.002
Hartman, 2001, Human peripheral blood eosinophils express stem cell factor, Blood, 97, 1086, 10.1182/blood.V97.4.1086
Piliponsky, 2002, Effects of eosinophils on mast cells: a new pathway for the perpetuation of allergic inflammation, Mol Immunol, 38, 1369, 10.1016/S0161-5890(02)00090-1
Solomon, 1998, Nerve growth factor is preformed in and activates human peripheral blood eosinophils, J Allergy Clin Immunol, 102, 454, 10.1016/S0091-6749(98)70135-6
Otani, 2013, Anti-IL-5 therapy reduces mast cell and IL-9 cell numbers in pediatric patients with eosinophilic esophagitis, J Allergy Clin Immunol, 131, 1576, 10.1016/j.jaci.2013.02.042
Lucey, 1989, Mature human eosinophils have the capacity to express HLA-DR, Proc Natl Acad Sci U S A, 86, 1348, 10.1073/pnas.86.4.1348
MacKenzie, 2001, Eosinophils promote allergic disease of the lung by regulating CD4(+) Th2 lymphocyte function, J Immunol, 167, 3146, 10.4049/jimmunol.167.6.3146
Wang, 2007, Airway eosinophils: allergic inflammation recruited professional antigen-presenting cells, J Immunol, 179, 7585, 10.4049/jimmunol.179.11.7585
Shi, 2000, Lymph node trafficking and antigen presentation by endobronchial eosinophils, J Clin Invest, 105, 945, 10.1172/JCI8945
Del Pozo, 1992, Eosinophil as antigen-presenting cell: activation of T cell clones and T cell hybridoma by eosinophils after antigen processing, Eur J Immunol, 22, 1919, 10.1002/eji.1830220736
Padigel, 2006, Eosinophils can function as antigen-presenting cells to induce primary and secondary immune responses to Strongyloides stercoralis, Infect Immun, 74, 3232, 10.1128/IAI.02067-05
Garro, 2011, Rat eosinophils stimulate the expansion of Cryptococcus neoformans-specific CD4(+) and CD8(+) T cells with a T-helper 1 profile, Immunology, 132, 174, 10.1111/j.1365-2567.2010.03351.x
Jacobsen, 2011, Eosinophils regulate dendritic cells and Th2 pulmonary immune responses following allergen provocation, J Immunol, 187, 6059, 10.4049/jimmunol.1102299
Jacobsen, 2015, Differential activation of airway eosinophils induces IL-13 mediated allergic Th2 pulmonary responses in mice, Allergy, 70, 1148, 10.1111/all.12655
Chu, 2014, Indigenous enteric eosinophils control DCs to initiate a primary Th2 immune response in vivo, J Exp Med, 211, 1657, 10.1084/jem.20131800
Chu, 2011, Eosinophils are required for the maintenance of plasma cells in the bone marrow, Nat Immunol, 12, 151, 10.1038/ni.1981
Chu, 2014, Eosinophils promote generation and maintenance of immunoglobulin-A-expressing plasma cells and contribute to gut immune homeostasis, Immunity, 40, 582, 10.1016/j.immuni.2014.02.014
Jung, 2015, IL-1β in eosinophil-mediated small intestinal homeostasis and IgA production, Mucosal Immunol, 8, 930, 10.1038/mi.2014.123
Todd, 1991, The eosinophil as a cellular source of transforming growth factor alpha in healing cutaneous wounds, Am J Pathol, 138, 1307
Ohno, 1995, Eosinophils as a potential source of platelet-derived growth factor B-chain (PDGF-B) in nasal polyposis and bronchial asthma, Am J Respir Cell Mol Biol, 13, 639, 10.1165/ajrcmb.13.6.7576701
Horiuchi, 1997, Expression of vascular endothelial growth factor by human eosinophils: upregulation by granulocyte macrophage colony-stimulating factor and interleukin-5, Am J Respir Cell Mol Biol, 17, 70, 10.1165/ajrcmb.17.1.2796
Stenfeldt, 2004, Danger signals derived from stressed and necrotic epithelial cells activate human eosinophils, Immunology, 112, 605, 10.1111/j.1365-2567.2004.01906.x
Goh, 2013, Eosinophils secrete IL-4 to facilitate liver regeneration, Proc Natl Acad Sci U S A, 110, 9914, 10.1073/pnas.1304046110
Heredia, 2013, Type 2 innate signals stimulate fibro/adipogenic progenitors to facilitate muscle regeneration, Cell, 153, 376, 10.1016/j.cell.2013.02.053
Aizawa, 2003, Molecular analysis of human Siglec-8 orthologs relevant to mouse eosinophils: identification of mouse orthologs of Siglec-5 (mSiglec-F) and Siglec-10 (mSiglec-G), Genomics, 82, 521, 10.1016/S0888-7543(03)00171-X
Ethier, 2014, Identification of human eosinophils in whole blood by flow cytometry, Methods Mol Biol, 1178, 81, 10.1007/978-1-4939-1016-8_8
Stevens, 2007, Detection and quantitation of eosinophils in the murine respiratory tract by flow cytometry, J Immunol Methods, 327, 63, 10.1016/j.jim.2007.07.011
Filley, 1981, An immunofluorescent method for specific staining of eosinophil granule major basic protein, J Immunol Methods, 47, 227, 10.1016/0022-1759(81)90123-X
Melo, 2005, Intragranular vesiculotubular compartments are involved in piecemeal degranulation by activated human eosinophils, Traffic, 6, 866, 10.1111/j.1600-0854.2005.00322.x
Kasperkiewicz, 2007, The pathophysiology of bullous pemphigoid, Clin Rev Allergy Immunol, 33, 67, 10.1007/s12016-007-0030-y
Jordon, 1967, Basement zone antibodies in bullous pemphigoid, JAMA, 200, 751, 10.1001/jama.200.9.751
Stanley, 1981, Characterization of bullous pemphigoid antigen: a unique basement membrane protein of stratified squamous epithelia, Cell, 24, 897, 10.1016/0092-8674(81)90115-X
Mutasim, 1985, A pool of bullous pemphigoid antigen(s) is intracellular and associated with the basal cell cytoskeleton-hemidesmosome complex, J Invest Dermatol, 84, 47, 10.1111/1523-1747.ep12274684
Labib, 1986, Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting, J Immunol, 136, 1231, 10.4049/jimmunol.136.4.1231
Kiss, 2005, Autoantibodies to human alpha6 integrin in patients with bullous pemphigoid, Ann N Y Acad Sci, 1051, 104, 10.1196/annals.1361.051
Bekou, 2005, Detection of laminin 5-specific auto-antibodies in mucous membrane and bullous pemphigoid sera by ELISA, J Invest Dermatol, 124, 732, 10.1111/j.0022-202X.2005.23646.x
Borradori, 1999, Structure and function of hemidesmosomes: more than simple adhesion complexes, J Invest Dermatol, 112, 411, 10.1046/j.1523-1747.1999.00546.x
Schmidt-Ullrich, 1975, Ultrastructural localization of in vivo-bound complement in bullous pemphigoid, J Invest Dermatol, 65, 217, 10.1111/1523-1747.ep12598218
Gammon, 1981, Leukocyte chemotaxis to the dermal-epidermal junction of human skin mediated by pemphigoid antibody and complement: mechanism of cell attachment in the in vitro leukocyte attachment method, J Invest Dermatol, 76, 514, 10.1111/1523-1747.ep12521246
Liu, 1995, The role of complement in experimental bullous pemphigoid, J Clin Invest, 95, 1539, 10.1172/JCI117826
Wintroub, 1978, Morphologic and functional evidence for release of mast-cell products in bullous pemphigoid, N Engl J Med, 298, 417, 10.1056/NEJM197802232980803
Dvorak, 1982, Bullous pemphigoid, an ultrastructural study of the inflammatory response: eosinophil, basophil and mast cell granule changes in multiple biopsies from one patient, J Invest Dermatol, 78, 91, 10.1111/1523-1747.ep12505711
Iryo, 1992, Ultrastructural aspects of infiltrated eosinophils in bullous pemphigoid, J Dermatol, 19, 393, 10.1111/j.1346-8138.1992.tb03247.x
Messingham, 2016, Eosinophil localization to the basement membrane zone is autoantibody- and complement-dependent in a human cryosection model of bullous pemphigoid, Exp Dermatol, 25, 50, 10.1111/exd.12883
Bushkell, 1983, Bullous pemphigoid: a cause of peripheral blood eosinophilia, J Am Acad Dermatol, 8, 648, 10.1016/S0190-9622(83)70073-3
Bernard, 1987, Blood eosinophilia as a severity marker for bullous pemphigoid, J Am Acad Dermatol, 16, 879, 10.1016/S0190-9622(87)80227-X
Marzano, 2009, Activation of blood coagulation in bullous pemphigoid: role of eosinophils, and local and systemic implications, Br J Dermatol, 160, 266, 10.1111/j.1365-2133.2008.08880.x
Yu, 2014, Omalizumab therapy for bullous pemphigoid, J Am Acad Dermatol, 71, 468, 10.1016/j.jaad.2014.04.053
Tedeschi, 2015, Eosinophil cationic protein levels parallel coagulation activation in the blister fluid of patients with bullous pemphigoid, J Eur Acad Dermatol Venereol, 29, 813, 10.1111/jdv.12464
Wakugawa, 2000, Elevated levels of eotaxin and interleukin-5 in blister fluid of bullous pemphigoid: correlation with tissue eosinophilia, Br J Dermatol, 143, 112, 10.1046/j.1365-2133.2000.03599.x
D’Auria, 1998, IL-5 levels in the serum and blister fluid of patients with bullous pemphigoid: correlations with eosinophil cationic protein, RANTES, IgE and disease severity, Arch Dermatol Res, 290, 25, 10.1007/s004030050272
Frezzolini, 2002, Increased expression of eotaxin and its specific receptor CCR3 in bullous pemphigoid, Eur J Dermatol, 12, 27
Engmann, 2017, Increased activity and apoptosis of eosinophils in blister fluids, skin and peripheral blood of patients with bullous pemphigoid, Acta Derm Venereol, 97, 464, 10.2340/00015555-2581
Borrego, 1996, Deposition of eosinophil granule proteins precedes blister formation in bullous pemphigoid. Comparison with neutrophil and mast cell granule proteins, Am J Pathol, 148, 897
Ståhle-Bäckdahl, 1994, 92-kD gelatinase is produced by eosinophils at the site of blister formation in bullous pemphigoid and cleaves the extracellular domain of recombinant 180-kD bullous pemphigoid autoantigen, J Clin Invest, 93, 2022, 10.1172/JCI117196
Niimi, 2006, Increased expression of matrix metalloproteinase-2, matrix metalloproteinase-9 and matrix metalloproteinase-13 in lesional skin of bullous pemphigoid, Int Arch Allergy Immunol, 139, 104, 10.1159/000090385
Verraes, 2001, Respective contribution of neutrophil elastase and matrix metalloproteinase 9 in the degradation of BP180 (type XVII collagen) in human bullous pemphigoid, J Invest Dermatol, 117, 1091, 10.1046/j.0022-202x.2001.01521.x
Sitaru, 2002, Autoantibodies to bullous pemphigoid antigen 180 induce dermal-epidermal separation in cryosections of human skin, J Invest Dermatol, 118, 664, 10.1046/j.1523-1747.2002.01720.x
Bernard, 1990, Immunoblot analysis of IgG subclasses of circulating antibodies in bullous pemphigoid, Clin Immunol Immunopathol, 54, 484, 10.1016/0090-1229(90)90060-4
Döpp, 2000, IgG4 and IgE are the major immunoglobulins targeting the NC16A domain of BP180 in Bullous pemphigoid: serum levels of these immunoglobulins reflect disease activity, J Am Acad Dermatol, 42, 577, 10.1016/S0190-9622(00)90168-3
Messingham, 2014, Human eosinophils express the high affinity IgE receptor, FcεRI, in bullous pemphigoid, PLoS One, 9, e107725, 10.1371/journal.pone.0107725
Hofmann, 2007, Bullous pemphigoid associated with hypereosinophilic syndrome: simultaneous response to imatinib, J Am Acad Dermatol, 56, S68, 10.1016/j.jaad.2006.02.059
Liu, 1993, A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180, J Clin Invest, 92, 2480, 10.1172/JCI116856
Hurskainen, 2015, Deletion of the major bullous pemphigoid epitope region of collagen XVII induces blistering, autoimmunization, and itching in mice, J Invest Dermatol, 135, 1303, 10.1038/jid.2014.443
Snook, 1990, Are the inflammatory bowel diseases autoimmune disorders?, Gut, 31, 961, 10.1136/gut.31.9.961
Bercovitz, 1966, Altered inflammatory reaction in nonspecific ulcerative colitis, Arch Intern Med, 117, 504, 10.1001/archinte.117.4.504
Rutgeerts, 1984, Natural history of recurrent Crohn’s disease at the ileocolonic anastomosis after curative surgery, Gut, 25, 665, 10.1136/gut.25.6.665
Walsh, 1991, The eosinophil in inflammatory bowel disease, Scand J Gastroenterol, 26, 1217, 10.3109/00365529108998617
Dubucquoi, 1995, Activated eosinophils and interleukin 5 expression in early recurrence of Crohn’s disease, Gut, 37, 242, 10.1136/gut.37.2.242
Makiyama, 1995, Activation of eosinophils in the pathophysiology of ulcerative colitis, J Gastroenterol, 30, 64
Saitoh, 1999, Fecal eosinophil granule-derived proteins reflect disease activity in inflammatory bowel disease, Am J Gastroenterol, 94, 3513, 10.1111/j.1572-0241.1999.01640.x
Jeziorska, 2001, Distribution and activation of eosinophils in inflammatory bowel disease using an improved immunohistochemical technique, J Pathol, 194, 484, 10.1002/path.904
Coburn, 2013, High-throughput multi-analyte Luminex profiling implicates eotaxin-1 in ulcerative colitis, PLoS One, 8, e82300, 10.1371/journal.pone.0082300
Zezos, 2014, Severe eosinophilic infiltration in colonic biopsies predicts patients with ulcerative colitis not responding to medical therapy, Colorectal Dis, 16, O420, 10.1111/codi.12725
Sadi, 2016, Prevalence of peripheral eosinophilia at diagnosis in children with inflammatory bowel disease, J Pediatr Gastroenterol Nutr, 62, 573, 10.1097/MPG.0000000000000957
Park, 2016, Histological disease activity as a predictor of clinical relapse among patients with ulcerative colitis: systematic review and meta-analysis, Am J Gastroenterol, 111, 1692, 10.1038/ajg.2016.418
Vieira, 2009, Treatment with a novel chemokine-binding protein or eosinophil lineage-ablation protects mice from experimental colitis, Am J Pathol, 175, 2382, 10.2353/ajpath.2009.090093
Griseri, 2015, Granulocyte macrophage colony-stimulating factor-activated eosinophils promote interleukin-23 driven chronic colitis, Immunity, 43, 187, 10.1016/j.immuni.2015.07.008
Radnai, 2016, Eosinophils contribute to intestinal inflammation via chemoattractant receptor-homologous molecule expressed on Th2 cells, CRTH2, in experimental Crohn’s disease, J Crohns Colitis, 10, 1087, 10.1093/ecco-jcc/jjw061
Chen, 2001, Increased serum levels of eotaxin in patients with inflammatory bowel disease, Scand J Gastroenterol, 36, 515, 10.1080/003655201750153377
Mir, 2002, Elevated serum eotaxin levels in patients with inflammatory bowel disease, Am J Gastroenterol, 97, 1452, 10.1111/j.1572-0241.2002.05687.x
Lampinen, 2013, CD14+CD33+ myeloid cell-CCL11-eosinophil signature in ulcerative colitis, J Leukoc Biol, 94, 1061, 10.1189/jlb.1212640
Takahashi, 2013, Regulation of eotaxin-3/CCL26 expression by Th2 cytokines in human colonic myofibroblasts, Clin Exp Immunol, 173, 323, 10.1111/cei.12117
Park, 2005, The association of eotaxin-2 and eotaxin-3 gene polymorphisms in a Korean population with ulcerative colitis, Exp Mol Med, 37, 553, 10.1038/emm.2005.68
Forbes, 2004, Immunopathogenesis of experimental ulcerative colitis is mediated by eosinophil peroxidase, J Immunol, 172, 5664, 10.4049/jimmunol.172.9.5664
Waddell, 2011, Colonic eosinophilic inflammation in experimental colitis is mediated by Ly6C(high) CCR2(+) inflammatory monocyte/macrophage-derived CCL11, J Immunol, 186, 5993, 10.4049/jimmunol.1003844
Dvorak, 1980, Ultrastructural evidence for release of major basic protein-containing crystalline cores of eosinophil granules in vivo: cytotoxic potential in Crohn’s disease, J Immunol, 125, 460, 10.4049/jimmunol.125.1.460
Nishitani, 1998, Infiltration of peroxidase-producing eosinophils into the lamina propria of patients with ulcerative colitis, J Gastroenterol, 33, 189, 10.1007/s005350050068
Bischoff, 1999, Immunnohistological assessment of intestinal eosinophil activation in patients with eosinophilic gastroenteritis and inflammatory bowel disease, Am J Gastroenterol, 94, 3521, 10.1111/j.1572-0241.1999.01641.x
Carlson, 1999, Increased intraluminal release of eosinophil granule proteins EPO, ECP, EPX, and cytokines in ulcerative colitis and proctitis in segmental perfusion, Am J Gastroenterol, 94, 1876, 10.1111/j.1572-0241.1999.01223.x
Levy, 1997, Increased eosinophil granule proteins in gut lavage fluid from patients with inflammatory bowel disease, Mayo Clin Proc, 72, 117, 10.4065/72.2.117
Pronk-Admiraal, 2000, Serum eosinophil cationic protein in active and quiescent ulcerative colitis, Clin Chem Lab Med, 38, 619, 10.1515/CCLM.2000.090
Wedrychowicz, 2014, Clinical value of serum eosinophilic cationic protein assessment in children with inflammatory bowel disease, Arch Med Sci, 10, 1142, 10.5114/aoms.2013.34415
Blom, 2012, Eosinophil associated genes in the inflammatory bowel disease 4 region: correlation to inflammatory bowel disease revealed, World J Gastroenterol, 18, 6409, 10.3748/wjg.v18.i44.6409
Lampinen, 2005, Eosinophil granulocytes are activated during the remission phase of ulcerative colitis, Gut, 54, 1714, 10.1136/gut.2005.066423
Furuta, 2005, Eosinophils alter colonic epithelial barrier function: role for major basic protein, Am J Physiol Gastrointest Liver Physiol, 289, G890, 10.1152/ajpgi.00015.2005
Wallon, 2011, Eosinophils express muscarinic receptors and corticotropin-releasing factor to disrupt the mucosal barrier in ulcerative colitis, Gastroenterology, 140, 1597, 10.1053/j.gastro.2011.01.042
Wolk, 2007, IL-22 induces lipopolysaccharide-binding protein in hepatocytes: a potential systemic role of IL-22 in Crohn’s disease, J Immunol, 178, 5973, 10.4049/jimmunol.178.9.5973
Andoh, 2005, Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts, Gastroenterology, 129, 969, 10.1053/j.gastro.2005.06.071
Sugimoto, 2008, IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis, J Clin Invest, 118, 534, 10.1172/JCI33194
Sonnenberg, 2010, Functional biology of the IL-22-IL-22R pathway in regulating immunity and inflammation at barrier surfaces, Adv Immunol, 107, 1, 10.1016/B978-0-12-381300-8.00001-0
Martin, 2016, IL-22BP is produced by eosinophils in human gut and blocks IL-22 protective actions during colitis, Mucosal Immunol, 9, 539, 10.1038/mi.2015.83
Owaga, 2015, Th17 cells as potential probiotic therapeutic targets in inflammatory bowel diseases, Int J Mol Sci, 16, 20841, 10.3390/ijms160920841
Willebrand, 2016, IL-33-induced cytokine secretion and survival of mouse eosinophils is promoted by autocrine GM-CSF, PLoS One, 11, e0163751, 10.1371/journal.pone.0163751
Churg, 1951, Allergic granulomatosis, allergic angiitis, and periarteritis nodosa, Am J Pathol, 27, 277
Lanham, 1984, Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome, Medicine (Baltimore), 63, 65, 10.1097/00005792-198403000-00001
Khoury, 2014, Eosinophils in vasculitis: characteristics and roles in pathogenesis, Nat Rev Rheumatol, 10, 474, 10.1038/nrrheum.2014.98
Mahr, 2014, Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): evolutions in classification, etiopathogenesis, assessment and management, Curr Opin Rheumatol, 26, 16, 10.1097/BOR.0000000000000015
Bonatti, 2014, Genetic susceptibility to ANCA-associated vasculitis: state of the art, Front Immunol, 5, 577, 10.3389/fimmu.2014.00577
Comarmond, 2013, Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort, Arthritis Rheum, 65, 270, 10.1002/art.37721
Moosig, 2013, A vasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg-Strauss, EGPA): monocentric experiences in 150 patients, Ann Rheum Dis, 72, 1011, 10.1136/annrheumdis-2012-201531
Hellmich, 2005, Proinflammatory cytokines and autoimmunity in Churg-Strauss syndrome, Ann N Y Acad Sci, 1051, 121, 10.1196/annals.1361.053
Jakiela, 2011, Both Th2 and Th17 responses are involved in the pathogenesis of Churg-Strauss syndrome, Clin Exp Rheumatol, 29, S23
Tsukadaira, 1999, Eosinophil active cytokines and surface analysis of eosinophils in Churg-Strauss syndrome, Allergy Asthma Proc, 20, 39, 10.2500/108854199778681486
Kiene, 2001, Elevated interleukin-4 and interleukin-13 production by T cell lines from patients with Churg-Strauss syndrome, Arthritis Rheum, 44, 469, 10.1002/1529-0131(200102)44:2<469::AID-ANR66>3.0.CO;2-0
Boita, 2014, The molecular and functional characterization of clonally expanded CD8+ TCR BV T cells in eosinophilic granulomatosis with polyangiitis (EGPA), Clin Immunol, 152, 152, 10.1016/j.clim.2014.03.001
Dallos, 2010, CCL17/thymus and activation-related chemokine in Churg-Strauss syndrome, Arthritis Rheum, 62, 3496, 10.1002/art.27678
Nakahigashi, 2013, A case of Churg-Strauss syndrome: flow cytometric analysis of the surface activation markers of peripheral eosinophils, Acta Derm Venereol, 93, 100, 10.2340/00015555-1384
Terrier, 2010, Interleukin-25: a cytokine linking eosinophils and adaptive immunity in Churg-Strauss syndrome, Blood, 116, 4523, 10.1182/blood-2010-02-267542
Jennette, 1998, Pathogenesis of the vascular and glomerular damage in ANCA-positive vasculitis, Nephrol Dial Transplant, 13, 16, 10.1093/ndt/13.suppl_1.16
Wiik, 2009, Clinical and pathophysiological significance of anti-neutrophil cytoplasmic autoantibodies in vasculitis syndromes, Mod Rheumatol, 19, 590, 10.1007/s10165-009-0219-4
Bajema, 2001, Colocalization of ANCA-antigens and fibrinoid necrosis in ANCA-associated vasculitis, Kidney Int, 60, 2025, 10.1046/j.1523-1755.2001.00019.x
Oka, 2011, Two subtypes of Churg-Strauss syndrome with neuropathy: the roles of eosinophils and ANCA, Mod Rheumatol, 21, 290, 10.1007/s10165-010-0400-9
Nagashima, 2002, Clinicopathological studies of peripheral neuropathy in Churg-Strauss syndrome, Neuropathology, 22, 299, 10.1046/j.1440-1789.2002.00454.x
Vital, 2006, Neuro-muscular biopsy in Churg-Strauss syndrome: 24 cases, J Neuropathol Exp Neurol, 65, 187, 10.1097/01.jnen.0000200151.60142.25
Chao, 2007, Skin denervation and cutaneous vasculitis in eosinophilia-associated neuropathy, Arch Neurol, 64, 959, 10.1001/archneur.64.7.959
Shah, 1990, Eosinophils from hypereosinophilic patients damage endocardium of isolated feline heart muscle preparations, Circulation, 81, 1081, 10.1161/01.CIR.81.3.1081
Tai, 1987, Deposits of eosinophil granule proteins in cardiac tissues of patients with eosinophilic endomyocardial disease, Lancet, 329, 643, 10.1016/S0140-6736(87)90412-0
Slungaard, 1991, Bromide-dependent toxicity of eosinophil peroxidase for endothelium and isolated working rat hearts: a model for eosinophilic endocarditis, J Exp Med, 173, 117, 10.1084/jem.173.1.117
Slungaard, 1993, Eosinophil cationic granule proteins impair thrombomodulin function. A potential mechanism for thromboembolism in hypereosinophilic heart disease, J Clin Invest, 91, 1721, 10.1172/JCI116382
Polzer, 2008, Eotaxin-3 is involved in Churg-Strauss syndrome – a serum marker closely correlating with disease activity, Rheumatology (Oxford), 47, 804, 10.1093/rheumatology/ken033
Zwerina, 2011, Eotaxin-3 in Churg-Strauss syndrome: a clinical and immunogenetic study, Rheumatology (Oxford), 50, 1823, 10.1093/rheumatology/keq445
Kim, 2010, Mepolizumab as a steroid-sparing treatment option in patients with Churg-Strauss syndrome, J Allergy Clin Immunol, 125, 1336, 10.1016/j.jaci.2010.03.028
Moosig, 2011, Targeting interleukin-5 in refractory and relapsing Churg-Strauss syndrome, Ann Intern Med, 155, 341, 10.7326/0003-4819-155-5-201109060-00026
Herrmann, 2012, Extended follow-up after stopping mepolizumab in relapsing/refractory Churg-Strauss syndrome, Clin Exp Rheumatol, 30, S62
Aretz, 1987, Myocarditis. A histopathologic definition and classification, Am J Cardiovasc Pathol, 1, 3
Cihakova, 2008, Pathogenesis of myocarditis and dilated cardiomyopathy, Adv Immunol, 99, 95, 10.1016/S0065-2776(08)00604-4
Frustaci, 2009, Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study, Eur Heart J, 30, 1995, 10.1093/eurheartj/ehp249
Weller, 1994, The idiopathic hypereosinophilic syndrome, Blood, 83, 2759, 10.1182/blood.V83.10.2759.2759
Parrillo, 1979, The cardiovascular manifestations of the hypereosinophilic syndrome. Prospective study of 26 patients, with review of the literature, Am J Med, 67, 572, 10.1016/0002-9343(79)90227-4
Ogbogu, 2007, Cardiovascular manifestations of hypereosinophilic syndromes, Immunol Allergy Clin North Am, 27, 457, 10.1016/j.iac.2007.07.001
Cottin, 2017, Revisiting the systemic vasculitis in eosinophilic granulomatosis with polyangiitis (Churg-Strauss): a study of 157 patients by the Groupe d’Etudes et de Recherche sur les Maladies Orphelines Pulmonaires and the European Respiratory Society Taskforce on eosinophilic granulomatosis with polyangiitis (Churg-Strauss), Autoimmun Rev, 16, 1, 10.1016/j.autrev.2016.09.018
Fauci, 1982, NIH conference. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations, Ann Intern Med, 97, 78, 10.7326/0003-4819-97-1-78
Parrillo, 1990, Heart disease and the eosinophil, N Engl J Med, 323, 1560, 10.1056/NEJM199011293232211
Tai, 1982, Toxic effects of human eosinophil products on isolated rat heart cells in vitro, Biochem J, 204, 75, 10.1042/bj2040075
deMello, 1990, Cardiac localization of eosinophil-granule major basic protein in acute necrotizing myocarditis, N Engl J Med, 323, 1542, 10.1056/NEJM199011293232207
Patella, 1997, Eosinophil granule proteins are selective activators of human heart mast cells, Int Arch Allergy Immunol, 113, 200, 10.1159/000237546
Cugno, 2014, Enhanced tissue factor expression by blood eosinophils from patients with hypereosinophilia: a possible link with thrombosis, PLoS One, 9, e111862, 10.1371/journal.pone.0111862
Lee, 1997, Expression of IL-5 in thymocytes/T cells leads to the development of a massive eosinophilia, extramedullary eosinophilopoiesis, and unique histopathologies, J Immunol, 158, 1332, 10.4049/jimmunol.158.3.1332
Diny, 2017, Eosinophil-derived IL4 drives progression of myocarditis to inflammatory dilated cardiomyopathy, J Exp Med, 214, 943, 10.1084/jem.20161702
Afanasyeva, 2001, Experimental autoimmune myocarditis in A/J mice is an interleukin-4-dependent disease with a Th2 phenotype, Am J Pathol, 159, 193, 10.1016/S0002-9440(10)61685-9
Barin, 2013, Fatal eosinophilic myocarditis develops in the absence of IFN-γ and IL-17A, J Immunol, 191, 4038, 10.4049/jimmunol.1301282
Ong, 2015, Natural killer cells limit cardiac inflammation and fibrosis by halting eosinophil infiltration, Am J Pathol, 185, 847, 10.1016/j.ajpath.2014.11.023
Daubeney, 2006, Clinical features and outcomes of childhood dilated cardiomyopathy: results from a national population-based study, Circulation, 114, 2671, 10.1161/CIRCULATIONAHA.106.635128
Magnani, 2006, Myocarditis: current trends in diagnosis and treatment, Circulation, 113, 876, 10.1161/CIRCULATIONAHA.105.584532
Pereira, 2015, Epidemiological, clinical, and immunological characteristics of neuromyelitis optica: a review, J Neurol Sci, 355, 7, 10.1016/j.jns.2015.05.034
Wingerchuk, 2006, Revised diagnostic criteria for neuromyelitis optica, Neurology, 66, 1485, 10.1212/01.wnl.0000216139.44259.74
Lucchinetti, 2002, A role for humoral mechanisms in the pathogenesis of Devic’s neuromyelitis optica, Brain, 125, 1450, 10.1093/brain/awf151
Saadoun, 2012, Paucity of natural killer and cytotoxic T cells in human neuromyelitis optica lesions, Neuroreport, 23, 1044, 10.1097/WNR.0b013e32835ab480
Hengstman, 2007, Neuromyelitis optica with clinical and histopathological involvement of the brain, Mult Scler, 13, 679, 10.1177/1352458506070145
Popescu, 2011, Neuromyelitis optica unique area postrema lesions: nausea, vomiting, and pathogenic implications, Neurology, 76, 1229, 10.1212/WNL.0b013e318214332c
Jarius, 2011, Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures, J Neurol Sci, 306, 82, 10.1016/j.jns.2011.03.038
Correale, 2004, Activation of humoral immunity and eosinophils in neuromyelitis optica, Neurology, 63, 2363, 10.1212/01.WNL.0000148481.80152.BF
Zhang, 2013, Eosinophil pathogenicity mechanisms and therapeutics in neuromyelitis optica, J Clin Invest, 123, 2306, 10.1172/JCI67554
Shi, 2012, Role of autoimmunity in primary biliary cirrhosis, World J Gastroenterol, 18, 7141, 10.3748/wjg.v18.i48.7141
Martinez, 1995, Cytokine patterns and cytotoxic mediators in primary biliary cirrhosis, Hepatology, 21, 113, 10.1016/0270-9139(95)90417-4
Nagano, 1999, Cytokine profile in the liver of primary biliary cirrhosis, J Clin Immunol, 19, 422, 10.1023/A:1020511002025
Yang, 2014, IL-12/Th1 and IL-23/Th17 biliary microenvironment in primary biliary cirrhosis: implications for therapy, Hepatology, 59, 1944, 10.1002/hep.26979
Qian, 2013, Increased IL-23 and IL-17 expression by peripheral blood cells of patients with primary biliary cirrhosis, Cytokine, 64, 172, 10.1016/j.cyto.2013.07.005
Rong, 2009, Imbalance between T helper type 17 and T regulatory cells in patients with primary biliary cirrhosis: the serum cytokine profile and peripheral cell population, Clin Exp Immunol, 156, 217, 10.1111/j.1365-2249.2009.03898.x
Terasaki, 1993, Eosinophilic infiltration of the liver in primary biliary cirrhosis: a morphological study, Hepatology, 17, 206, 10.1002/hep.1840170208
Yamazaki, 1996, Eosinophilia in primary biliary cirrhosis, Am J Gastroenterol, 91, 516
Nakamura, 1997, Increased portal tract infiltration of mast cells and eosinophils in primary biliary cirrhosis, Am J Gastroenterol, 92, 2245
Yamazaki, 1999, Ursodeoxycholic acid inhibits eosinophil degranulation in patients with primary biliary cirrhosis, Hepatology, 30, 71, 10.1002/hep.510300121
Takiguchi, 2005, Anti-eosinophil peroxidase antibodies detected in patients with primary biliary cirrhosis, Hepatol Res, 32, 33, 10.1016/j.hepres.2005.01.013
Irie, 2006, NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis, J Exp Med, 203, 1209, 10.1084/jem.20051911
Ambrosini, 2011, The multi-hit hypothesis of primary biliary cirrhosis: polyinosinic-polycytidylic acid (poly I:C) and murine autoimmune cholangitis, Clin Exp Immunol, 166, 110, 10.1111/j.1365-2249.2011.04453.x
Concepcion, 2015, Mouse models of primary biliary cirrhosis, Curr Pharm Des, 21, 2401, 10.2174/1381612821666150316121622
Wirth, 1994, [Eosinophilia in primary biliary cirrhosis: regression under therapy with ursodeoxycholic acid], Schweiz Med Wochenschr, 124, 810
Willart, 2012, Ursodeoxycholic acid suppresses eosinophilic airway inflammation by inhibiting the function of dendritic cells through the nuclear farnesoid X receptor, Allergy, 67, 1501, 10.1111/all.12019
Zachou, 2004, Primary biliary cirrhosis presented as peripheral eosinophilia in asymptomatic women with or without elevated alkaline phosphatase, Eur J Gastroenterol Hepatol, 16, 425, 10.1097/00042737-200404000-00011
Gazzaruso, 2003, Early diagnosis of primary biliary cirrhosis in type 1 diabetes: the possible role of eosinophilia, Diabetes Care, 26, 2963, 10.2337/diacare.26.10.2963
Long, 2016, Eosinophilic skin diseases: a comprehensive review, Clin Rev Allergy Immunol, 50, 189, 10.1007/s12016-015-8485-8
Simon, 2003, Interleukin-2 primes eosinophil degranulation in hypereosinophilia and Wells’ syndrome, Eur J Immunol, 33, 834, 10.1002/eji.200323727
Peters, 1983, Immunofluorescence identification of eosinophil granule major basic protein in the flame figures of Wells’ syndrome, Br J Dermatol, 109, 141, 10.1111/j.1365-2133.1983.tb07074.x
Wouters, 2015, Mass spectrometry of flame figures, Acta Derm Venereol, 95, 734, 10.2340/00015555-2050
Soragni, 2015, Toxicity of eosinophil MBP is repressed by intracellular crystallization and promoted by extracellular aggregation, Mol Cell, 57, 1011, 10.1016/j.molcel.2015.01.026
Fujimura, 2014, A possible mechanism in the recruitment of eosinophils and Th2 cells through CD163+ M2 macrophages in the lesional skin of eosinophilic cellulitis, Eur J Dermatol, 24, 180, 10.1684/ejd.2014.2283
Shulman, 1975, Diffuse fasciitis with eosinophilia: a new syndrome?, Trans Assoc Am Physicians, 88, 70
Shulman, 1984, Diffuse fasciitis with hypergammaglobulinemia and eosinophilia: a new syndrome?, J Rheumatol, 11, 569
Pinal-Fernandez, 2014, Diagnosis and classification of eosinophilic fasciitis, Autoimmun Rev, 13, 379, 10.1016/j.autrev.2014.01.019
Lebeaux, 2012, Eosinophilic fasciitis (Shulman disease), Best Pract Res Clin Rheumatol, 26, 449, 10.1016/j.berh.2012.08.001
Lakhanpal, 1988, Eosinophilic fasciitis: clinical spectrum and therapeutic response in 52 cases, Semin Arthritis Rheum, 17, 221, 10.1016/0049-0172(88)90008-X
Endo, 2007, Eosinophilic fasciitis: report of two cases and a systematic review of the literature dealing with clinical variables that predict outcome, Clin Rheumatol, 26, 1445, 10.1007/s10067-006-0525-6
Lebeaux, 2012, Eosinophilic fasciitis (Shulman disease): new insights into the therapeutic management from a series of 34 patients, Rheumatology (Oxford, England), 51, 557, 10.1093/rheumatology/ker366
Deshpande, 2012, Consensus statement on the pathology of IgG4-related disease, Mod Pathol, 25, 1181, 10.1038/modpathol.2012.72
Kamisawa, 2015, IgG4-related disease, Lancet (London, England), 385, 1460, 10.1016/S0140-6736(14)60720-0
Della-Torre, 2015, Immunology of IgG4-related disease, Clin Exp Immunol, 181, 191, 10.1111/cei.12641
Umehara, 2012, Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011, Mod Rheumatol, 22, 21, 10.3109/s10165-011-0571-z
Khosroshahi, 2012, Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients, Medicine, 91, 57, 10.1097/MD.0b013e3182431ef6
Della Torre, 2014, Prevalence of atopy, eosinophilia, and IgE elevation in IgG4-related disease, Allergy, 69, 269, 10.1111/all.12320
Ishida, 1996, Hypereosinophilic syndrome with generalized myasthenia gravis, J Pediatr, 128, 369, 10.1016/S0022-3476(96)70284-6
Markusse, 1998, Hypereosinophilic syndrome presenting with diarrhoea and anaemia in a patient with systemic lupus erythematosus, Neth J Med, 52, 79, 10.1016/S0300-2977(97)00086-7
Thomeer, 1999, Systemic lupus erythematosus, eosinophilia and Löffler’s endocarditis. An unusual association, Eur Respir J, 13, 930, 10.1034/j.1399-3003.1999.13d38.x
Kane, 1977, Ulcerative colitis with chronic liver disease, eosinophilia and auto-immune thyroid disease, Postgrad Med J, 53, 105, 10.1136/pgmj.53.616.105
Chaudhuri, 2002, Idiopathic hypereosinophilic syndrome in a patient with long-standing rheumatoid arthritis: a case report, Rheumatology (Oxford), 41, 349, 10.1093/rheumatology/41.3.349
Bonanno, 2003, [Idiopathic hypereosinophilic syndrome associated with rheumatoid arthritis. A case report], Reumatismo, 55, 181
Habibagahi, 2009, Systemic lupus erythematosus and hyper-eosinophilic syndrome: an unusual association, West Indian Med J, 58, 69
Aydoğdu, 2010, A case of systemic lupus erythematosus presenting with hypereosinophilia and Loeffler endocarditis, Acta Cardiol, 65, 571, 10.2143/AC.65.5.2056245
Katz, 2005, Pediatric hypereosinophilic syndrome (HES) differs from adult HES, J Pediatr, 146, 134, 10.1016/j.jpeds.2004.09.014
Terrier, 2007, Coexistence and parallel evolution of hypereosinophilic syndrome, autoimmune hepatitis, and ulcerative colitis suggest common pathogenic features, Am J Gastroenterol, 102, 1132, 10.1111/j.1572-0241.2007.01180_9.x
Awano, 2011, Successful treatment of ulcerative colitis associated with hypereosinophilic syndrome/chronic eosinophilic leukemia, Intern Med, 50, 1741, 10.2169/internalmedicine.50.5569
Darki, 2011, Hypereosinophilic syndrome with cardiac involvement in a pregnant patient with multiple sclerosis, Tex Heart Inst J, 38, 163
Koneru, 2013, Hypereosinophilic syndrome associated with ulcerative colitis presenting with recurrent Loeffler’s endocarditis and left ventricular thrombus treated successfully with immune suppressive therapy and anticoagulation, BMJ Case Rep, 2013, 10.1136/bcr-2013-200919
Rosenstein, 2014, Hypereosinophilia and seroconversion of rheumatoid arthritis, Clin Rheumatol, 33, 1685, 10.1007/s10067-014-2566-6
Moxey, 2016, Rheumatoid arthritis heralded by the hypereosinophilic syndrome, Intern Med J, 46, 988, 10.1111/imj.13152
Kharabish, 2015, Cardiac MRI findings of endomyocardial fibrosis (Loeffler’s endocarditis) in a patient with rheumatoid arthritis, J Saudi Heart Assoc, 27, 127, 10.1016/j.jsha.2014.11.002
Roufosse, 2013, Long-term safety of mepolizumab for the treatment of hypereosinophilic syndromes, J Allergy Clin Immunol, 131, 461, 10.1016/j.jaci.2012.07.055
Lecouffe-Desprets, 2016, Eosinophilic gastrointestinal disorders associated with autoimmune connective tissue disease, Joint Bone Spine, 83, 479, 10.1016/j.jbspin.2015.11.006
Peterson, 2016, Risk of autoimmunity in EoE and families: a population-based cohort study, Am J Gastroenterol, 111, 926, 10.1038/ajg.2016.185
Sleiman, 2014, GWAS identifies four novel eosinophilic esophagitis loci, Nat Commun, 5, 5593, 10.1038/ncomms6593
Amin, 2000, Inflammation and structural changes in the airways of patients with atopic and nonatopic asthma, Am J Respir Crit Care Med, 162, 2295, 10.1164/ajrccm.162.6.9912001
Tedeschi, 2008, Asthma and autoimmunity: a complex but intriguing relation, Expert Rev Clin Immunol, 4, 767, 10.1586/1744666X.4.6.767
Taillé, 2016, Periplakin is a target for autoimmunity in asthma, Respir Res, 17, 126, 10.1186/s12931-016-0441-5
Kero, 2001, Could TH1 and TH2 diseases coexist? Evaluation of asthma incidence in children with coeliac disease, type 1 diabetes, or rheumatoid arthritis: a register study, J Allergy Clin Immunol, 108, 781, 10.1067/mai.2001.119557
Sheikh, 2003, There is no evidence of an inverse relationship between TH2-mediated atopy and TH1-mediated autoimmune disorders: lack of support for the hygiene hypothesis, J Allergy Clin Immunol, 111, 131, 10.1067/mai.2003.8
Hemminki, 2010, Subsequent autoimmune or related disease in asthma patients: clustering of diseases or medical care?, Ann Epidemiol, 20, 217, 10.1016/j.annepidem.2009.11.007
Tirosh, 2006, Autoimmune diseases in asthma, Ann Intern Med, 144, 877, 10.7326/0003-4819-144-12-200606200-00004
Thormann, 2016, Inverse comorbidity in multiple sclerosis: findings in a complete nationwide cohort, Mult Scler Relat Disord, 10, 181, 10.1016/j.msard.2016.10.008
van den Berge, 2009, The role of female sex hormones in the development and severity of allergic and non-allergic asthma, Clin Exp Allergy, 39, 1477, 10.1111/j.1365-2222.2009.03354.x
Knudsen, 2009, A population-based clinical study of allergic and non-allergic asthma, J Asthma, 46, 91, 10.1080/02770900802524657
Leynaert, 2012, Gender differences in prevalence, diagnosis and incidence of allergic and non-allergic asthma: a population-based cohort, Thorax, 67, 625, 10.1136/thoraxjnl-2011-201249
Schleimer, 1994, The effects of glucocorticoids on human eosinophils, J Allergy Clin Immunol, 94, 1202, 10.1016/0091-6749(94)90333-6